These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 9790519)

  • 1. Antioxidant content in low density lipoprotein and lipoprotein oxidation in vivo and in vitro.
    Tertov VV; Sobenin IA; Kaplun VV; Orekhov AN
    Free Radic Res; 1998 Aug; 29(2):165-73. PubMed ID: 9790519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of native and naturally occurring multiple modified low density lipoprotein in smooth muscle cells of human aortic intima.
    Tertov VV; Orekhov AN
    Exp Mol Pathol; 1997; 64(3):127-45. PubMed ID: 9439479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How different constituents of human plasma and low density lipoprotein determine plasma oxidizability by copper.
    Spranger T; Finckh B; Fingerhut R; Kohlschütter A; Beisiegel U; Kontush A
    Chem Phys Lipids; 1998 Jan; 91(1):39-52. PubMed ID: 9488998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How different constituents of low density lipoprotein determine its oxidizability by copper: a correlational approach.
    Kontush A; Hübner C; Finckh B; Kohlschütter A; Beisiegel U
    Free Radic Res; 1996 Feb; 24(2):135-47. PubMed ID: 8845914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ex vivo low-density lipoprotein oxidizability and in vivo lipid peroxidation in patients on CAPD.
    Roob JM; Rabold T; Hayn M; Khoschsorur G; Resch U; Holzer H; Winklhofer-Roob BM
    Kidney Int Suppl; 2001 Feb; 78():S128-36. PubMed ID: 11168998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Content of antioxidants, preformed lipid hydroperoxides, and cholesterol as predictors of the susceptibility of human LDL to metal ion-dependent and -independent oxidation.
    Frei B; Gaziano JM
    J Lipid Res; 1993 Dec; 34(12):2135-45. PubMed ID: 8301232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of correlation between degree of human plasma low density lipoprotein oxidation and its atherogenic potential.
    Tertov VV; Kaplun VV; Orekhov AN
    Biofactors; 1997; 6(2):139-43. PubMed ID: 9259995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo oxidized low density lipoprotein: degree of lipoprotein oxidation does not correlate with its atherogenic properties.
    Tertov VV; Kaplun VV; Orekhov AN
    Mol Cell Biochem; 1998 Jun; 183(1-2):141-6. PubMed ID: 9655188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-density lipoprotein modification occurring in human plasma possible mechanism of in vivo lipoprotein desialylation as a primary step of atherogenic modification.
    Tertov VV; Kaplun VV; Sobenin IA; Orekhov AN
    Atherosclerosis; 1998 May; 138(1):183-95. PubMed ID: 9678784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein B-bound lipids as a marker for evaluation of low density lipoprotein oxidation in vivo.
    Tertov VV; Kaplun VV; Dvoryantsev SN; Orekhov AN
    Biochem Biophys Res Commun; 1995 Sep; 214(2):608-13. PubMed ID: 7677772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole plasma oxidation assay as a measure of lipoprotein oxidizability.
    Kontush A; Spranger T; Reich A; Djahansouzi S; Karten B; Braesen JH; Finckh B; Kohlschütter A; Beisiegel U
    Biofactors; 1997; 6(2):99-109. PubMed ID: 9259991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple-modified desialylated low density lipoproteins that cause intracellular lipid accumulation. Isolation, fractionation and characterization.
    Tertov VV; Sobenin IA; Gabbasov ZA; Popov EG; Jaakkola O; Solakivi T; Nikkari T; Smirnov VN; Orekhov AN
    Lab Invest; 1992 Nov; 67(5):665-75. PubMed ID: 1434544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid composition of circulating multiple-modified low density lipoprotein.
    Zakiev ER; Sukhorukov VN; Melnichenko AA; Sobenin IA; Ivanova EA; Orekhov AN
    Lipids Health Dis; 2016 Aug; 15(1):134. PubMed ID: 27558696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-density lipoprotein composition and oxidability in atherosclerotic cardiovascular disease.
    Schreier LE; Sanguinetti S; Mosso H; Lopez GI; Siri L; Wikinski RL
    Clin Biochem; 1996 Oct; 29(5):479-87. PubMed ID: 8884071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol.
    Stocker R; Bowry VW; Frei B
    Proc Natl Acad Sci U S A; 1991 Mar; 88(5):1646-50. PubMed ID: 2000375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of lipid-soluble antioxidants in lipoproteins from healthy subjects. I. Correlation with plasma antioxidant levels and composition of lipoproteins.
    Perugini C; Bagnati M; Cau C; Bordone R; Zoppis E; Paffoni P; Re R; Albano E; Bellomo G
    Pharmacol Res; 2000 Jan; 41(1):55-65. PubMed ID: 10600270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antioxidants decreases the intensification of low density lipoprotein in vivo peroxidation during therapy with statins.
    Lankin VZ; Tikhaze AK; Kukharchuk VV; Konovalova GG; Pisarenko OI; Kaminnyi AI; Shumaev KB; Belenkov YN
    Mol Cell Biochem; 2003 Jul; 249(1-2):129-40. PubMed ID: 12956408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naturally occurring modified low density lipoproteins are similar if not identical: more electronegative and desialylated lipoprotein subfractions.
    Tertov VV; Bittolo-Bon G; Sobenin IA; Cazzolato G; Orekhov AN; Avogaro P
    Exp Mol Pathol; 1995 Jun; 62(3):166-72. PubMed ID: 8612720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in low-density lipoprotein electronegativity and oxidizability after aerobic exercise are related to the increase in associated non-esterified fatty acids.
    Benítez S; Sánchez-Quesada JL; Lucero L; Arcelus R; Ribas V; Jorba O; Castellví A; Alonso E; Blanco-Vaca F; Ordóñez-Llanos J
    Atherosclerosis; 2002 Jan; 160(1):223-32. PubMed ID: 11755941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidation of apolipoprotein B-100 in circulating LDL is related to LDL residence time. In vivo insights from stable-isotope studies.
    Pietzsch J; Lattke P; Julius U
    Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):E63-7. PubMed ID: 11031225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.